Edgewise Therapeutics, Inc.
EWTX • NASDAQ
Edgewise Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kevin Koch, with a market cap of $3.3B.
CEOKevin Koch
Next Earnings
Upcoming earnings announcement for Edgewise Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.49
Earnings History
Past 12 earnings reports for Edgewise Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | -$0.47Est: -$0.44 | -6.8% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.39Est: -$0.40 | +2.5% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.34Est: -$0.42 | +19.0% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.43Est: -$0.37 | -16.2% | - | — | 10-Q |
| Mar 3, 2025 | Q4 2024 | -$0.42Est: -$0.40 | -5.0% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.36Est: -$0.37 | +2.7% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.34Est: -$0.36 | +5.6% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.33Est: -$0.39 | +15.4% | - | — | 10-Q |
| Feb 22, 2024 | Q4 2023 | -$0.47Est: -$0.43 | -9.3% | -Est: - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.41Est: -$0.40 | -2.5% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.34Est: -$0.40 | +15.0% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.36Est: -$0.36 | 0.0% | - | — | — |